In patients undergoing pancreaticoduodenectomy (PD) for pancreatic adenocarcinoma (PC), conversion to total pancreatectomy (TP) may be necessary to achieve R0 resection.
We sought to examine the oncologic benefit of conversion of PD to TP to achieve an R0 resection in patients with an isolated positive neck margin.
We conducted a retrospective analysis of prospectively collected data at Indiana University and Johns Hopkins Medical Institutions. A review of 1,579 patients who underwent PD or TP for PC at these institutions between 1992 and 2006 was performed. Sixty-one patients were eligible.
Twenty-eight patients underwent PD with an isolated positive neck margin found on pathologic examination; 33 patients had conversion to TP for isolated neck margin involvement to achieve R0 resection. Patients undergoing TP versus PD had a greater median survival (18 vs 10 months; P = .04). Mortality (6% vs 7%) and morbidity (36% vs 54%; P = .20) for TP versus PD were comparable. Multivariate analysis revealed PD and greater tumor size as the only independent predictors of poor long-term survival (hazard ratio [HR], 2.2; P = .01 and HR, 1.3; P = .005).
Conversion of PD to TP to achieve an R0 resection in patients with pancreatic adenocarcinoma is associated with a survival benefit.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Cancer statistics, 2007.CA Cancer J Clin. 2007; 57: 43-66
- Survival after pancreaticoduodenectomy: 118 consecutive resections without an operative mortality.Ann Surg. 1987; 206: 358-365
- Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.Ann Surg. 1997; 226: 248-260
- Pancreaticoduodenectomy: a 20-year experience in 516 patients.Arch Surg. 2004; 139: 718-725
- Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators.J Gastrointestinal Surg. 2000; 4: 567-579
- Total pancreatectomy.Ann Surg. 1970; 172: 595-604
- 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience.J Gastrointest Surg. 2006; 10: 1199-1210
- Further evaluation of total pancreatectomy.Arch Surg. 1975; 110: 506-512
- Standards for pancreatic resection in the 1990s.Arch Surg. 1995; 130: 295-300
- Decreased morbidity and mortality after pancreatoduodenectomy.Am J Surg. 1986; 151: 141-149
- Frozen section diagnosis of pancreatic lesions.Arch Pathol Lab Med. 2002; 126: 1169-1173
- Pancreaticoduodenectomy with or without extended retroperitoneal lympadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome.Ann Surg. 1999; 229: 613-622
- Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma—part 3: update on 5-year survival.J Gastrointest Surg. 2005; 9: 1191-1206
- A prospective randomized trial comparing standard pancreaticoduodenectomy with pancreaticoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma.Surgery. 2005; 138: 618-628
- Regional versus extended lymph node dissection in radical pancreatoduodenectomy for pancreatic cancer: a multicenter, randomized controlled trial.HPB. 2004; 6: 2
- Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up?.J Gastrointestinal Surg. 2005; 9: 1059-1067
- The effects of regionalization on cost and outcome for one general high-risk surgical procedure.Ann Surg. 1995; 221: 43-49
- Importance of hospital volume in the management of pancreatic cancer.Surg Forum. 1997; 48: 584-586
- Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy.Ann Surg. 1995; 222: 638-645
Accepted: July 13, 2007
© 2007 Mosby, Inc. Published by Elsevier Inc. All rights reserved.